comparemela.com

Latest Breaking News On - Vestmark advisory solutions inc - Page 8 : comparemela.com

UiPath (NYSE:PATH) Trading Down 0 8%

UiPath Inc. (NYSE:PATH – Get Free Report)’s stock price traded down 0.8% during mid-day trading on Tuesday . The company traded as low as $18.49 and last traded at $18.83. 3,701,516 shares changed hands during mid-day trading, a decline of 54% from the average session volume of 7,962,141 shares. The stock had previously closed at […]

90,428 Shares in Johnson & Johnson (NYSE:JNJ) Acquired by Focus Financial Network Inc ADV

Focus Financial Network Inc. ADV bought a new position in Johnson & Johnson (NYSE:JNJ – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 90,428 shares of the company’s stock, valued at approximately $14,174,000. A number of other hedge funds also recently […]

Evermay Wealth Management LLC Sells 1,260 Shares of Johnson & Johnson (NYSE:JNJ)

Evermay Wealth Management LLC lowered its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 14.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 7,199 shares of the company’s stock after selling 1,260 shares during the quarter. Evermay Wealth Management […]

Invitae (NYSE:NVTA) Coverage Initiated at StockNews com

Research analysts at StockNews.com started coverage on shares of Invitae (NYSE:NVTA – Get Free Report) in a research note issued to investors on Saturday. The firm set a “hold” rating on the medical research company’s stock. Invitae Price Performance NVTA opened at $0.02 on Friday. Invitae has a 1-year low of $0.02 and a 1-year […]

Craig Hallum Trims Skyline Champion (NYSE:SKY) Target Price to $84 00

Skyline Champion (NYSE:SKY – Free Report) had its target price lowered by Craig Hallum from $88.00 to $84.00 in a research note issued to investors on Thursday morning, Benzinga reports. The firm currently has a buy rating on the stock. Other equities research analysts also recently issued reports about the stock. Wedbush reiterated a neutral […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.